Alphagen

What Is the AccuraCap AlphaGen PMS?

AccuraCap AlphaGen PMS is a long-only, discretionary multi-cap Portfolio Management Service strategy that can allocate across large-, mid- and small-cap companies. Its objective is capital appreciation through a diversified equity portfolio selected using AccuraCap's proprietary ranking framework.

The strategy dates back to 31 December 2015 and uses the S&P BSE 500 TRI as its benchmark. APMI describes its objective as investing across a diversified combination of large-, mid- and small-cap stocks across multiple sectors.

Rather than relying exclusively on conventional fundamental research, AlphaGen combines business fundamentals, valuation and price behaviour within a quantitative ranking framework. AccuraCap's published methodology also refers to spatio-temporal analysis, seasonality-adjusted 20-quarter trends and quality-of-earnings and governance screening. 

As of 31 July 2026, AltPort's APMI-sourced performance table reports AlphaGen's 1-year return at 9.94%, against 2.98% for the benchmark. Since-inception performance should always be read alongside its reporting methodology, applicable fees and the date of measurement. 

AccuraCap AlphaGen PMS: Fund Snapshot 

Source: APMI and Business Today; AUM and performance data dated June/July 2026. Business Today reports the ₹50 lakh minimum, 12–35-company investment objective and multi-cap/flexi-cap classification. APMI reports ₹49.28 crore AUM.

Note: The older AltPort page displays ₹64 crore AUM and a 30–50-stock range. Those figures are retained here only as historical page data and are not treated as the latest figures. The current APMI record reports ₹49.28 crore, while the published investment objective specifies 12–35 companies. 

AccuraCap AlphaGen PMS Investment Objective and Multi-Cap Strategy

The central objective of AlphaGen is to build a diversified equity portfolio by selecting companies across different market-cap segments rather than restricting the strategy to one portion of the market.

This gives the portfolio manager flexibility to participate in opportunities across large, mid and small companies. The approach can therefore change the portfolio's market-cap composition as rankings, valuations and business fundamentals evolve.

The selection framework broadly considers four interconnected areas:

• Growth: Revenue, core earnings and cash-flow trends.
• Business quality: Profitability, margins, ROCE and balance-sheet strength.
• Valuation: The attractiveness of a company relative to its peers, the broader universe and its own historical valuation.
• Momentum: Short-, medium- and long-term stock-price behaviour.

AccuraCap describes the methodology as a combination of business growth, stock value and price momentum with risk controls. Its framework also uses GARP — Growth at a Reasonable Price — rather than treating high growth alone as sufficient for portfolio inclusion. 

The multi-cap structure can provide diversification across market-cap segments, but it does not remove equity-market risk. A portfolio can underperform its benchmark when selected stocks, sectors or market-cap segments lag the broader market.

AccuraCap AlphaGen PMS Investment Universe and Portfolio Construction

AlphaGen's older product information describes an investment universe of approximately the top 700 companies by market capitalisation. The current portfolio objective, however, is more useful for understanding the strategy: it seeks to own a diversified portfolio of approximately 12–35 high-quality companies. 

Business Today describes AlphaGen as a multi-cap strategy with an average holding period of around two years and annual rebalancing, while also reporting a 30–40-stock construction description. Because the published sources are not completely consistent on portfolio-size terminology, this page uses the 12–35-company objective disclosed in the strategy material rather than presenting the 30–40 figure as a separate confirmed range. 

Portfolio construction follows the ranking system rather than a discretionary attempt to predict short-term market movements. Stocks that fall below the relevant ranking cut-off may be removed and replaced by higher-ranked candidates. Business Today also reports sector exposure limits and exclusions such as public-sector stocks and IPOs; investors should confirm the latest portfolio management agreement or strategy document before treating these as binding rules. 

The APMI record shows 1-year turnover of 0.92 as of 30 June 2026, providing a useful indication that the strategy does not necessarily involve constant trading.

How Does AccuraCap AlphaGen Select and Rank Stocks?

Earnings Quality and Governance Screening

The process starts with reported financial information. AccuraCap's framework includes filtering and scrubbing financial data before conducting a quality-of-earnings analysis.

The objective is to distinguish reported accounting performance from the underlying economic performance of a business. This can involve examining revenue trends, core earnings and cash flows rather than relying on a single headline profit number.

Corporate governance is another screening layer. Promoter-related concerns, business-quality issues and other governance factors can influence a company's ranking.

This matters because quantitative investing is only as reliable as the data entering the model. Poor-quality or misleading inputs can affect the resulting ranking, which is why financial-data screening forms an important first stage.

Core Earnings and Balance-Sheet Analysis

The next stage moves from reported earnings toward the underlying strength of the business.

AccuraCap's published methodology evaluates:

• Long-term earnings trends
• Revenue and core earnings
• Cash-flow generation
• Profit margins
• Return on Capital Employed
• Balance-sheet strength
• Solvency
• Liquidity
• Return on marginal invested capital

The framework uses 20-quarter trend analysis, adjusted for seasonality. This helps the ranking process assess whether a company's operating performance is improving, deteriorating or remaining relatively stable over a longer period. 

Quantitative Ranking Factors

The stock-ranking model combines fundamental and market information.

A simplified view of the ranking framework is:

AccuraCap refers to this as spatio-temporal ranking, meaning the analysis considers both relationships across companies and changes through time. The methodology is designed to make stock selection more systematic rather than relying entirely on individual judgement. 

Portfolio Selection and Position Sizing

After stocks are ranked, the higher-ranked companies form the investable portfolio subject to the strategy's construction parameters.

This is where quantitative analysis becomes portfolio management. A company can score well on one factor but still fail to qualify if other elements of its financial or risk profile weaken.

The result is a concentrated but diversified portfolio rather than a portfolio holding every stock in the broader market. Individual investor portfolios may differ because PMS accounts are separately managed and can be affected by account size, investment timing and client-specific restrictions.

How Does AlphaGen Review, Rebalance and Manage Turnover?

AlphaGen follows a ranking-driven portfolio management process. Stocks are reviewed according to their relative position within the investment framework, and securities whose rankings weaken can be replaced by stronger candidates. 

Business Today describes the strategy as being rebalanced once a year, with an average holding period of approximately two years. The APMI data also reports 1-year turnover of 0.92 as of 30 June 2026. These figures provide context but should not be interpreted as a fixed holding period for every security. 

Tax Considerations for PMS Investors

PMS taxation depends on the nature of transactions, applicable tax rules, investor circumstances and the treatment of gains. A historical holding period does not by itself guarantee a particular tax outcome.

Investors should review the latest tax treatment with a qualified tax professional and rely on the relevant transaction statements and current regulations before estimating post-tax returns.

What Role Do AI and Algorithms Play in the AlphaGen PMS?

AlphaGen uses a quantitative ranking framework to process financial and market information consistently. AccuraCap's published material describes its stock-selection process as using a proprietary algorithm and artificial intelligence/data-driven analysis. 

The important distinction is that an AI-assisted or algorithmic PMS is not a market-prediction machine.

The model can help organise large datasets, identify relationships and apply predefined ranking criteria consistently. It cannot guarantee that a company will deliver earnings growth, that a valuation will normalise, or that a stock will outperform.

Model risk also remains relevant. Historical backtesting can provide information about how a framework behaved over a particular dataset and period, but it cannot guarantee future results.

AccuraCap AlphaGen PMS Risk Metrics and Key Risks

AlphaGen is an equity PMS, so investors should expect market-linked returns and the possibility of capital loss.

The current AltPort page reports the following historical risk statistics, although these figures should be displayed with their underlying reporting period and source when published:

Source: AltPort's published AlphaGen data; reporting period/date should be retained with the underlying factsheet when this table is updated. 

Understanding AlphaGen's Risk Metrics

Standard deviation indicates the historical variability of returns. A higher number generally means greater fluctuations around the average return.

Sharpe ratio compares excess return with overall volatility. It can help assess how much return was generated relative to the volatility taken.

Sortino ratio is similar but focuses more specifically on downside volatility.

Excess return compares the portfolio's return with its benchmark over the relevant period.

These metrics should not be viewed individually. A lower volatility number does not automatically mean lower investment risk, just as a higher Sharpe ratio does not guarantee future outperformance.

Key Risks Investors Should Review

AlphaGen investors should consider:

• Equity-market risk: Stock prices can fall sharply.
• Multi-cap allocation risk: Exposure to smaller companies can increase volatility and liquidity risk.
• Liquidity risk: Some securities may be harder to buy or sell without affecting prices.
• Model risk: Quantitative rankings can produce incorrect signals.
• Valuation risk: A seemingly inexpensive company can remain undervalued or deteriorate further.
• Business risk: Earnings, margins or cash flows can weaken unexpectedly.
• Governance risk: Company-specific governance issues can affect valuations.
• Benchmark risk: AlphaGen can underperform the S&P BSE 500 TRI over certain periods.

Historical returns should therefore be considered alongside drawdowns, volatility and periods of benchmark underperformance.

AccuraCap AlphaGen PMS Portfolio: Top Holdings, Sector and Market-Cap Allocation

The latest portfolio information available through Business Today, dated 31 May 2026, shows the following model allocation:

Top Holdings

Source: Business Today, portfolio data as of 31 May 2026. Holdings can change and individual PMS accounts may differ. 

Market-Cap Allocation

Source: Business Today, data as of 31 May 2026. 

Sector Allocation

Source: Business Today, data as of 31 May 2026. The table shows the largest disclosed sector exposures, not the complete portfolio. 

The allocation illustrates why AlphaGen should not be treated as a conventional large-cap strategy. Although the May 2026 portfolio had a majority large-cap allocation, more than 48% was allocated to mid- and small-cap stocks combined. Market-cap exposure can change as the ranking model and portfolio composition evolve.

AccuraCap AlphaGen PMS: Fees, Minimum Investment and Exit Load

The minimum investment reported for AlphaGen is ₹50 lakh. Business Today currently reports the following fee structure:

Source: Business Today, accessed August 2026. Investors should confirm the applicable fee schedule, custody, brokerage, taxes and other charges in the current PMS agreement before investing. 

The fee structure should be understood carefully. A fixed management fee and variable/performance-linked component can affect an investor's net return. The hurdle rate is the threshold above which the reported performance-sharing arrangement applies according to the published fee structure.

Fees are subject to the applicable PMS documentation and may change. The signed agreement and latest fee schedule should take precedence over secondary-source summaries when comparing PMS strategies.

Who Should Consider AccuraCap AlphaGen PMS?

AlphaGen may be considered by investors who:

• Can meet the ₹50 lakh PMS minimum investment.
• Have a long-term equity investment horizon.
• Are comfortable with market-linked returns and periods of underperformance.
• Want exposure across large-, mid- and small-cap Indian equities.
• Prefer a quantitative, ranking-driven investment process.
• Understand that the portfolio can change its market-cap and sector exposure over time.
• Can tolerate liquidity and volatility risks associated with equity investing.

It may not suit investors looking for guaranteed capital protection, predictable returns or a strategy that remains concentrated in one market-cap segment.

The key point is simple: multi-cap diversification does not mean low risk. AlphaGen can still experience meaningful drawdowns when equity markets fall or when its selected stocks lag the benchmark.

How ALTPORT Helps Investors Access AccuraCap AlphaGen PMS

AltPort provides product information and facilitates access to PMS documentation and onboarding coordination. AccuraCap Consultancy Services Pvt. Ltd. manages the AlphaGen portfolio; AltPort does not select or manage the securities in the portfolio.

Investors can request the latest AlphaGen factsheet, performance information, fee details and application documentation through AltPort. The relevant PMS agreement and official disclosures should be reviewed before making an investment decision.

For investors comparing different portfolio management services, AlphaGen can be assessed alongside other strategies based on investment objective, market-cap exposure, historical performance, risk, fees and portfolio construction.